Sensei Biotherapeutics secures $200 million in a concurrent Private Placement while acquiring Faeth Therapeutics to advance its cancer pipeline.
Amount Raised
$200 Million
Round Type
Post-IPO Equity
AustinBiotechnologyHealth CareMedicalTherapeuticsresearchInvestors
Description
Sensei Biotherapeutics, Inc. has acquired Faeth Therapeutics Inc. and secured a $200 million financing through the sale of Series B non-voting convertible preferred stock. This funding will help advance its pipeline, particularly the investigational drug PIKTOR, through key clinical milestones in cancer treatment
Who to call at Faeth Therapeutics, and when
A new round usually means Faeth Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Faeth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Faeth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Faeth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Faeth Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Faeth Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.